Y

Ysios Capital portfolio

Ysios Capital has 3 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months. It led 1 of the 5 rounds it joined. Its most recent investment on record is Ona Therapeutics's $86.6M Series B+ round in June 2026, alongside Mérieux Equity Partners, Columbus Venture Partners, Korys and 6 others. By category, its portfolio leans toward Health and bio (3). It has co-invested with Asabys Partners, Bpifrance and Fund+, most often Asabys Partners (4 rounds).

What Ysios Capital invests in

• Health and bio · 3 · 100%

Ysios Capital recent investments

Company	Round	Date	Alongside
OOna Therapeutics	Series B+ · $86.6M	Jun 4, 2026	Mérieux Equity Partners (lead), Columbus Venture Partners (lead), Korys +6
SSplice Bio	Series B+ · $140M	Jun 11, 2025	UCB Ventures, Sanofi Ventures (lead), Roche Venture Fund +5
EEngrail Therapeutics	Series B+ · $157M	Mar 19, 2024	RiverVest, Red Tree Venture Capital, Pivotal Life Sciences +6
SSplice Bio	Series A · $57M · lead	Feb 1, 2022	UCB Ventures (lead), Novartis Venture Fund, NEA +2
OOna Therapeutics	Series A · $33.92M	Jun 16, 2020	Fund+, Bpifrance, Asabys Partners +1

How Ysios Capital invests

Share is of the 5 rounds on Recent Funding that name Ysios Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Ysios Capital portfolio companies

• OOna Therapeutics$86.6MSeries B+ · Jun 2026
• SSplice Bio$140MSeries B+ · Jun 2025
• EEngrail Therapeutics$157MSeries B+ · Mar 2024

Company	Round with Ysios Capital	Total raised	Latest raise
OOna Therapeutics Health and bio	Jun 4, 2026 Series B+ · $86.6M	$207.12M	Oct 5, 2026 Series B+
SSplice Bio Health and bio	Jun 11, 2025 Series B+ · $140M	$197M	Jun 11, 2025 Series B+
EEngrail Therapeutics Health and bio	Mar 19, 2024 Series B+ · $157M	$221M	Mar 19, 2024 Series B+

Most frequent co-investors

• AAsabys Partners4 shared rounds · last Jun 4, 2026
• BBpifrance2 shared rounds · last Jun 4, 2026
• FFund+2 shared rounds · last Jun 4, 2026
• AAlta Life Sciences2 shared rounds · last Jun 4, 2026
• NNEA2 shared rounds · last Jun 11, 2025
• GGilde Healthcare2 shared rounds · last Jun 11, 2025
• UUCB Ventures2 shared rounds · last Jun 11, 2025
• NNovartis Venture Fund2 shared rounds · last Jun 11, 2025
• CCOFIDES1 shared round · last Jun 4, 2026
• MMérieux Equity Partners1 shared round · last Jun 4, 2026
• CColumbus Venture Partners1 shared round · last Jun 4, 2026
• KKorys1 shared round · last Jun 4, 2026

Similar investors

• PPositive Sum3 companies · 4 deals in 12 mo
• BBlue Cloud Ventures3 companies · 3 deals in 12 mo
• IInnovestor3 companies · 3 deals in 12 mo
• FFrazier Life Sciences3 companies · 2 deals in 12 mo
• KKadmos Capital3 companies · 2 deals in 12 mo
• KKorea Credit Guarantee Fund3 companies · 2 deals in 12 mo

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Ysios Capital, which is a subset of its real portfolio. API: /api/v1/investors/ysios-capital (get a free API key). More: the most active VC firms and new venture capital funds.